InsidersTradesSigma
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Frommer Kathy, Director. Director active across 2 companies, notably REPRO MED SYSTEMS INC. Cumulatively, 7 reports have been recorded. History available since 30 June 2021. The latest transaction was filed on 31 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
7 of 7 declarations
Kathy Frommer serves as a Board Member at Repro Med Systems Inc. She is involved in the governance of the company, bringing her expertise in medical systems. Repro Med Systems specializes in developing innovative solutions for healthcare. Ms. Frommer's experience enables her to make significant contributions to the strategic discussions of the board.